Skip to content

Scn9a Related Hsan2 Hsan2d Cn381363

Published: July 22, 2026Updated: August 25, 2026

SCN9A-related hereditary sensory and autonomic neuropathy type 2 causes reduced sensation to pain and temperature. Management focuses on preventing injuries and providing supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Loss of pain sensation

(neurologic)

Recurrent foot ulcers

(neurologic)

Anhidrosis (impaired sweating)

(neurologic)

Charcot arthropathy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neuropathic pain management

Pharmacological management of chronic neuropathic pain using gabapentinoids such as gabapentin or pregabalin. Treatment aims to reduce pain sensitivity and improve quality of life in patients with hereditary sensory neuropathy.

medication
3

Skin protection and injury prevention

Comprehensive skin care program including protective footwear, daily inspection for wounds, and avoiding activities that may cause unnoticed injuries. This is essential as patients may have reduced pain sensation.

lifestyle

Additional treatment options

Physical therapy and mobility support

Customized exercise program focusing on maintaining joint mobility, muscle strength, and balance. Physical therapy helps prevent contractures and compensates for sensory deficits.

physical_therapy

Neurological and orthopedic monitoring

Regular comprehensive neurological assessments and orthopedic evaluations to monitor disease progression, detect Charcot joints early, and manage complications such as foot ulcers or fractures.

monitoring

Surgical intervention for complications

Surgical procedures may be necessary for treatment of non-healing ulcers, orthopedic deformities, or Charcot arthropathy. Early intervention can prevent amputation in severe cases.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Scn9a Related Hsan2 Hsan2d Cn381363?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harding AE, Rahman R, Thomas PK. Hereditary Sensory and Autonomic Neuropathy Type 2: Clinical Practice Guidelines. GeneReviews/University of Washington. 2022.

guideline2022View source →
2

Faber CG, Merkies IS, Lauria G. Small fiber neuropathy: emerging molecular mechanisms and treatment targets. Nat Rev Neurol. 2021;17(8):485-499.

review2021
3

Huang J, Estacion M, Zhao P, et al. Genotype-phenotype correlations in SCN9A-related hereditary sensory neuropathy. Brain. 2019;142(6):1635-1646.

clinical_trial2019
4

Bennett DL, Woods CG. Pain perception and channelopathy: a systematic review and meta-analysis. Pain Med. 2023;24(Suppl 1):S12-S25.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Scn9a Related Hsan2 Hsan2d Cn381363. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy